Eli Lilly To Pay $13.5M, Cap Monthly Insulin Costs In National Class Action
NEWARK, N.J. — Eli Lilly & Co. has agreed to pay $13.5 million for an insulin price claims fund and to ensure that class members will have prices for certain Lilly...To view the full article, register now.
Already a subscriber? Click here to view full article